skip to primary navigationskip to content
 

10.05.16 Steve Jackson wins the 2016 Dr A.H. Heineken Prize for Medicine

last modified May 10, 2016 11:19 AM
The Gurdon Institute's Steve Jackson, Quick Professor of Biology at the University of Cambridge and the Institute's head of Cancer Research UK Laboratories, has won the 2016 Heineken Prize for Medicine.
10.05.16  Steve Jackson wins the 2016 Dr A.H. Heineken Prize for Medicine

Steve Jackson [photo credit KNAW/Jussi Puikkonen].

Professor Steve Jackson will receive the prestigious Dr A.H. Heineken Prize for Medicine, value $200,000, for his "fundamental research into DNA repair in human cells and for the successful application of knowledge of that process in the development of new cancer drugs".

The prize is conferred by the Royal Netherlands Academy of Arts and Sciences, along with others in Biochemistry and Biophysics, Environmental Sciences, Cognitive Science, History and Art.

The Heineken Prizes are the largest international research prizes in the Netherlands and are awarded every other year. The winners are selected by juries consisting of leading international researchers put together by the Academy.

The prizes are named after Dr Henry P. Heineken (1886-1971), Dr Alfred H. Heineken (1923-2002) and Charlene de Carvalho-Heineken (1954-). Charlene de Carvalho-Heineken is chair of the Dr H.P. Heineken Foundation and the Alfred Heineken Fondsen Foundation, which finance the prizes. 

"It is a great honour and privilege to receive the 2016 Dr A.H. Heineken Prize for Medicine," said Jackson, adding: "I would like to thank all the many dedicated, innovative and highly talented people who have worked in my laboratory, as it is their groundbreaking science that has led to me receiving this award. I also express my deepest thanks to my mentors and inspirational colleagues in the Gurdon Institute at Cambridge University for their invaluable support and advice over the years."

The prize-giving ceremony will take place in September 2016 in Amsterdam's Stock Exchange building, the Beurs van Berlage, now a grand venue for municipal events and conferences.

 

More about research in the Jackson group.

Studying development to understand disease

The Gurdon Institute is funded by Wellcome and Cancer Research UK to study the biology of development, and how normal growth and maintenance go wrong in cancer and other diseases.

combinedLogo x3 trans2018

 

Share this

Tissue-specific profiling reveals distinctive regulatory architectures for ubiquitous, germline and somatic genes

Tailless/TLX reverts intermediate neural progenitors to stem cells driving tumourigenesis via repression of asense/ASCL1

On growth and force: mechanical forces in development

Chronic irradiation of human cells reduces histone levels and deregulates gene expression

PALB2 chromatin recruitment restores homologous recombination in BRCA1-deficient cells depleted of 53BP1

Activin A and BMP4 Signaling Expands Potency of Mouse Embryonic Stem Cells in Serum-Free Media

The myeloid lineage is required for the emergence of a regeneration permissive environment following Xenopus tail amputation

Filopodia and their links with membrane traffic and cell adhesion

Ancestral Hybridisation Facilitated Species Diversification in the Lake Malawi Cichlid Fish Adaptive Radiation

Mapping and editing animal mitochondrial genomes: can we overcome the challenges?

The role of integrins in Drosophila egg chamber morphogenesis

A Genome-wide Screen Reveals that Reducing Mitochondrial DNA Polymerase Can Promote Elimination of Deleterious Mitochondrial Mutations

Genetic predisposition to mosaic Y chromosome loss in blood

MDC1 PST-repeat region promotes histone H2AX-independent chromatin association and DNA damage tolerance

Checkpoint inhibition of origin firing prevents DNA topological stress

Small Molecule Inhibition of UBE2T/FANCL-mediated Ubiquitylation in the Fanconi Anemia Pathway

Link to full list on PubMed